nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxyurea—head and neck cancer—sarcoma	0.792	1	CtDrD
Hydroxyurea—RRM1—larynx—sarcoma	0.00783	0.173	CbGeAlD
Hydroxyurea—RRM2—mammary gland—sarcoma	0.00305	0.0673	CbGeAlD
Hydroxyurea—RRM2—Vinorelbine—Vincristine—sarcoma	0.0028	1	CbGdCrCtD
Hydroxyurea—RRM1—mammary gland—sarcoma	0.00254	0.0559	CbGeAlD
Hydroxyurea—RRM2—myometrium—sarcoma	0.00217	0.0478	CbGeAlD
Hydroxyurea—RRM2—embryo—sarcoma	0.00208	0.046	CbGeAlD
Hydroxyurea—RRM2—hematopoietic system—sarcoma	0.00186	0.041	CbGeAlD
Hydroxyurea—RRM1—myometrium—sarcoma	0.0018	0.0397	CbGeAlD
Hydroxyurea—RRM1—seminal vesicle—sarcoma	0.00163	0.0359	CbGeAlD
Hydroxyurea—RRM2—skin of body—sarcoma	0.00162	0.0357	CbGeAlD
Hydroxyurea—RRM1—hematopoietic system—sarcoma	0.00154	0.0341	CbGeAlD
Hydroxyurea—RRM2—uterus—sarcoma	0.0014	0.031	CbGeAlD
Hydroxyurea—RRM1—smooth muscle tissue—sarcoma	0.00136	0.03	CbGeAlD
Hydroxyurea—RRM1—skin of body—sarcoma	0.00134	0.0296	CbGeAlD
Hydroxyurea—RRM2—lymphoid tissue—sarcoma	0.00131	0.0289	CbGeAlD
Hydroxyurea—RRM2—tendon—sarcoma	0.00123	0.0272	CbGeAlD
Hydroxyurea—RRM2—bone marrow—sarcoma	0.00119	0.0263	CbGeAlD
Hydroxyurea—RRM1—cardiac atrium—sarcoma	0.00117	0.0259	CbGeAlD
Hydroxyurea—RRM1—uterus—sarcoma	0.00117	0.0257	CbGeAlD
Hydroxyurea—RRM1—lymphoid tissue—sarcoma	0.00109	0.024	CbGeAlD
Hydroxyurea—RRM1—tendon—sarcoma	0.00102	0.0226	CbGeAlD
Hydroxyurea—RRM2—testis—sarcoma	0.00102	0.0225	CbGeAlD
Hydroxyurea—RRM1—bone marrow—sarcoma	0.00099	0.0219	CbGeAlD
Hydroxyurea—RRM2—liver—sarcoma	0.000963	0.0213	CbGeAlD
Hydroxyurea—RRM1—testis—sarcoma	0.000846	0.0187	CbGeAlD
Hydroxyurea—RRM1—liver—sarcoma	0.0008	0.0177	CbGeAlD
Hydroxyurea—RRM2—lymph node—sarcoma	0.000739	0.0163	CbGeAlD
Hydroxyurea—RRM1—lymph node—sarcoma	0.000614	0.0135	CbGeAlD
Hydroxyurea—CYP2D6—hematopoietic system—sarcoma	0.000459	0.0101	CbGeAlD
Hydroxyurea—CYP2D6—testis—sarcoma	0.000251	0.00555	CbGeAlD
Hydroxyurea—CYP2D6—liver—sarcoma	0.000238	0.00525	CbGeAlD
Hydroxyurea—Chills—Mitoxantrone—sarcoma	0.000208	0.0013	CcSEcCtD
Hydroxyurea—Leukopenia—Dactinomycin—sarcoma	0.000208	0.0013	CcSEcCtD
Hydroxyurea—Skin exfoliation—Epirubicin—sarcoma	0.000206	0.00128	CcSEcCtD
Hydroxyurea—Alopecia—Mitoxantrone—sarcoma	0.000205	0.00128	CcSEcCtD
Hydroxyurea—Blood urea increased—Epirubicin—sarcoma	0.000203	0.00127	CcSEcCtD
Hydroxyurea—Hepatobiliary disease—Etoposide—sarcoma	0.000203	0.00127	CcSEcCtD
Hydroxyurea—Blood uric acid increased—Doxorubicin—sarcoma	0.000203	0.00127	CcSEcCtD
Hydroxyurea—Convulsion—Thiotepa—sarcoma	0.000203	0.00127	CcSEcCtD
Hydroxyurea—Erythema—Mitoxantrone—sarcoma	0.000202	0.00126	CcSEcCtD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—sarcoma	0.000198	0.00124	CcSEcCtD
Hydroxyurea—Rash maculo-papular—Epirubicin—sarcoma	0.000196	0.00122	CcSEcCtD
Hydroxyurea—Discomfort—Dactinomycin—sarcoma	0.000195	0.00122	CcSEcCtD
Hydroxyurea—Neoplasm—Epirubicin—sarcoma	0.000195	0.00122	CcSEcCtD
Hydroxyurea—Pulmonary oedema—Epirubicin—sarcoma	0.000192	0.0012	CcSEcCtD
Hydroxyurea—Anaemia—Vincristine—sarcoma	0.000192	0.0012	CcSEcCtD
Hydroxyurea—Skin exfoliation—Doxorubicin—sarcoma	0.00019	0.00119	CcSEcCtD
Hydroxyurea—Infection—Thiotepa—sarcoma	0.00019	0.00118	CcSEcCtD
Hydroxyurea—Oedema—Dactinomycin—sarcoma	0.000189	0.00118	CcSEcCtD
Hydroxyurea—Infection—Dactinomycin—sarcoma	0.000188	0.00118	CcSEcCtD
Hydroxyurea—Blood urea increased—Doxorubicin—sarcoma	0.000188	0.00118	CcSEcCtD
Hydroxyurea—Ill-defined disorder—Mitoxantrone—sarcoma	0.000187	0.00117	CcSEcCtD
Hydroxyurea—Nervous system disorder—Thiotepa—sarcoma	0.000187	0.00117	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Thiotepa—sarcoma	0.000187	0.00117	CcSEcCtD
Hydroxyurea—Anaemia—Mitoxantrone—sarcoma	0.000187	0.00117	CcSEcCtD
Hydroxyurea—Leukopenia—Vincristine—sarcoma	0.000186	0.00116	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Dactinomycin—sarcoma	0.000185	0.00116	CcSEcCtD
Hydroxyurea—Skin disorder—Thiotepa—sarcoma	0.000185	0.00116	CcSEcCtD
Hydroxyurea—Malaise—Mitoxantrone—sarcoma	0.000182	0.00114	CcSEcCtD
Hydroxyurea—Anorexia—Thiotepa—sarcoma	0.000182	0.00114	CcSEcCtD
Hydroxyurea—Rash maculo-papular—Doxorubicin—sarcoma	0.000181	0.00113	CcSEcCtD
Hydroxyurea—Leukopenia—Mitoxantrone—sarcoma	0.000181	0.00113	CcSEcCtD
Hydroxyurea—Anorexia—Dactinomycin—sarcoma	0.000181	0.00113	CcSEcCtD
Hydroxyurea—Neoplasm—Doxorubicin—sarcoma	0.00018	0.00113	CcSEcCtD
Hydroxyurea—Convulsion—Vincristine—sarcoma	0.00018	0.00112	CcSEcCtD
Hydroxyurea—Pulmonary oedema—Doxorubicin—sarcoma	0.000177	0.00111	CcSEcCtD
Hydroxyurea—Angiopathy—Etoposide—sarcoma	0.000175	0.00109	CcSEcCtD
Hydroxyurea—Convulsion—Mitoxantrone—sarcoma	0.000175	0.00109	CcSEcCtD
Hydroxyurea—Hepatic failure—Epirubicin—sarcoma	0.000174	0.00109	CcSEcCtD
Hydroxyurea—Chills—Etoposide—sarcoma	0.000173	0.00108	CcSEcCtD
Hydroxyurea—Alopecia—Etoposide—sarcoma	0.000171	0.00107	CcSEcCtD
Hydroxyurea—Discomfort—Mitoxantrone—sarcoma	0.00017	0.00106	CcSEcCtD
Hydroxyurea—Somnolence—Thiotepa—sarcoma	0.00017	0.00106	CcSEcCtD
Hydroxyurea—Renal failure acute—Epirubicin—sarcoma	0.000169	0.00106	CcSEcCtD
Hydroxyurea—Oedema—Vincristine—sarcoma	0.000169	0.00106	CcSEcCtD
Hydroxyurea—Infection—Vincristine—sarcoma	0.000168	0.00105	CcSEcCtD
Hydroxyurea—Dyspepsia—Thiotepa—sarcoma	0.000168	0.00105	CcSEcCtD
Hydroxyurea—Nervous system disorder—Vincristine—sarcoma	0.000166	0.00104	CcSEcCtD
Hydroxyurea—Decreased appetite—Thiotepa—sarcoma	0.000166	0.00104	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Vincristine—sarcoma	0.000166	0.00104	CcSEcCtD
Hydroxyurea—Oedema—Mitoxantrone—sarcoma	0.000165	0.00103	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Thiotepa—sarcoma	0.000165	0.00103	CcSEcCtD
Hydroxyurea—Decreased appetite—Dactinomycin—sarcoma	0.000165	0.00103	CcSEcCtD
Hydroxyurea—Fatigue—Thiotepa—sarcoma	0.000165	0.00103	CcSEcCtD
Hydroxyurea—Infection—Mitoxantrone—sarcoma	0.000164	0.00102	CcSEcCtD
Hydroxyurea—Dermatitis bullous—Epirubicin—sarcoma	0.000164	0.00102	CcSEcCtD
Hydroxyurea—Fatigue—Dactinomycin—sarcoma	0.000163	0.00102	CcSEcCtD
Hydroxyurea—Constipation—Thiotepa—sarcoma	0.000163	0.00102	CcSEcCtD
Hydroxyurea—Pain—Thiotepa—sarcoma	0.000163	0.00102	CcSEcCtD
Hydroxyurea—Pain—Dactinomycin—sarcoma	0.000162	0.00101	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Mitoxantrone—sarcoma	0.000161	0.00101	CcSEcCtD
Hydroxyurea—Anorexia—Vincristine—sarcoma	0.000161	0.00101	CcSEcCtD
Hydroxyurea—Hepatic failure—Doxorubicin—sarcoma	0.000161	0.00101	CcSEcCtD
Hydroxyurea—Skin disorder—Mitoxantrone—sarcoma	0.00016	0.001	CcSEcCtD
Hydroxyurea—Feeling abnormal—Thiotepa—sarcoma	0.000157	0.000982	CcSEcCtD
Hydroxyurea—Anorexia—Mitoxantrone—sarcoma	0.000157	0.000981	CcSEcCtD
Hydroxyurea—Renal failure acute—Doxorubicin—sarcoma	0.000157	0.000979	CcSEcCtD
Hydroxyurea—Feeling abnormal—Dactinomycin—sarcoma	0.000156	0.000975	CcSEcCtD
Hydroxyurea—Ill-defined disorder—Etoposide—sarcoma	0.000156	0.000974	CcSEcCtD
Hydroxyurea—Anaemia—Etoposide—sarcoma	0.000155	0.00097	CcSEcCtD
Hydroxyurea—Malaise—Etoposide—sarcoma	0.000152	0.000946	CcSEcCtD
Hydroxyurea—Dermatitis bullous—Doxorubicin—sarcoma	0.000151	0.000946	CcSEcCtD
Hydroxyurea—Face oedema—Epirubicin—sarcoma	0.000151	0.000943	CcSEcCtD
Hydroxyurea—Body temperature increased—Thiotepa—sarcoma	0.000151	0.000942	CcSEcCtD
Hydroxyurea—Leukopenia—Etoposide—sarcoma	0.00015	0.000939	CcSEcCtD
Hydroxyurea—Body temperature increased—Dactinomycin—sarcoma	0.00015	0.000935	CcSEcCtD
Hydroxyurea—Decreased appetite—Vincristine—sarcoma	0.000147	0.000919	CcSEcCtD
Hydroxyurea—Dyspnoea—Mitoxantrone—sarcoma	0.000147	0.000918	CcSEcCtD
Hydroxyurea—Somnolence—Mitoxantrone—sarcoma	0.000147	0.000915	CcSEcCtD
Hydroxyurea—Blood creatinine increased—Epirubicin—sarcoma	0.000147	0.000915	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Vincristine—sarcoma	0.000146	0.000913	CcSEcCtD
Hydroxyurea—Fatigue—Vincristine—sarcoma	0.000146	0.000911	CcSEcCtD
Hydroxyurea—Convulsion—Etoposide—sarcoma	0.000146	0.000909	CcSEcCtD
Hydroxyurea—Dyspepsia—Mitoxantrone—sarcoma	0.000145	0.000906	CcSEcCtD
Hydroxyurea—Pain—Vincristine—sarcoma	0.000145	0.000904	CcSEcCtD
Hydroxyurea—Constipation—Vincristine—sarcoma	0.000145	0.000904	CcSEcCtD
Hydroxyurea—Decreased appetite—Mitoxantrone—sarcoma	0.000143	0.000895	CcSEcCtD
Hydroxyurea—Fatigue—Mitoxantrone—sarcoma	0.000142	0.000888	CcSEcCtD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.000142	0.000887	CcSEcCtD
Hydroxyurea—Discomfort—Etoposide—sarcoma	0.000141	0.000883	CcSEcCtD
Hydroxyurea—Breast disorder—Epirubicin—sarcoma	0.000141	0.000883	CcSEcCtD
Hydroxyurea—Pain—Mitoxantrone—sarcoma	0.000141	0.00088	CcSEcCtD
Hydroxyurea—Constipation—Mitoxantrone—sarcoma	0.000141	0.00088	CcSEcCtD
Hydroxyurea—Hypersensitivity—Thiotepa—sarcoma	0.000141	0.000878	CcSEcCtD
Hydroxyurea—Face oedema—Doxorubicin—sarcoma	0.00014	0.000872	CcSEcCtD
Hydroxyurea—Hypersensitivity—Dactinomycin—sarcoma	0.00014	0.000872	CcSEcCtD
Hydroxyurea—Asthenia—Thiotepa—sarcoma	0.000137	0.000855	CcSEcCtD
Hydroxyurea—Infection—Etoposide—sarcoma	0.000136	0.000851	CcSEcCtD
Hydroxyurea—Asthenia—Dactinomycin—sarcoma	0.000136	0.000849	CcSEcCtD
Hydroxyurea—Feeling abnormal—Mitoxantrone—sarcoma	0.000136	0.000848	CcSEcCtD
Hydroxyurea—Blood creatinine increased—Doxorubicin—sarcoma	0.000136	0.000847	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Etoposide—sarcoma	0.000134	0.000838	CcSEcCtD
Hydroxyurea—Body temperature increased—Vincristine—sarcoma	0.000134	0.000836	CcSEcCtD
Hydroxyurea—Skin disorder—Etoposide—sarcoma	0.000133	0.000832	CcSEcCtD
Hydroxyurea—Pancreatitis—Epirubicin—sarcoma	0.000133	0.000828	CcSEcCtD
Hydroxyurea—Breast disorder—Doxorubicin—sarcoma	0.000131	0.000817	CcSEcCtD
Hydroxyurea—Anorexia—Etoposide—sarcoma	0.000131	0.000816	CcSEcCtD
Hydroxyurea—Diarrhoea—Thiotepa—sarcoma	0.000131	0.000816	CcSEcCtD
Hydroxyurea—Body temperature increased—Mitoxantrone—sarcoma	0.00013	0.000814	CcSEcCtD
Hydroxyurea—Diarrhoea—Dactinomycin—sarcoma	0.00013	0.00081	CcSEcCtD
Hydroxyurea—Pancytopenia—Epirubicin—sarcoma	0.000128	0.000802	CcSEcCtD
Hydroxyurea—Dysuria—Epirubicin—sarcoma	0.000126	0.000789	CcSEcCtD
Hydroxyurea—Neutropenia—Epirubicin—sarcoma	0.000126	0.000789	CcSEcCtD
Hydroxyurea—Dizziness—Thiotepa—sarcoma	0.000126	0.000788	CcSEcCtD
Hydroxyurea—Hypersensitivity—Vincristine—sarcoma	0.000125	0.000779	CcSEcCtD
Hydroxyurea—Weight increased—Epirubicin—sarcoma	0.000123	0.000768	CcSEcCtD
Hydroxyurea—Pancreatitis—Doxorubicin—sarcoma	0.000123	0.000766	CcSEcCtD
Hydroxyurea—Dyspnoea—Etoposide—sarcoma	0.000122	0.000763	CcSEcCtD
Hydroxyurea—Somnolence—Etoposide—sarcoma	0.000122	0.000761	CcSEcCtD
Hydroxyurea—Hypersensitivity—Mitoxantrone—sarcoma	0.000121	0.000759	CcSEcCtD
Hydroxyurea—Asthenia—Vincristine—sarcoma	0.000121	0.000758	CcSEcCtD
Hydroxyurea—Vomiting—Thiotepa—sarcoma	0.000121	0.000758	CcSEcCtD
Hydroxyurea—Infestation—Epirubicin—sarcoma	0.000121	0.000753	CcSEcCtD
Hydroxyurea—Infestation NOS—Epirubicin—sarcoma	0.000121	0.000753	CcSEcCtD
Hydroxyurea—Drowsiness—Epirubicin—sarcoma	0.000121	0.000753	CcSEcCtD
Hydroxyurea—Vomiting—Dactinomycin—sarcoma	0.00012	0.000752	CcSEcCtD
Hydroxyurea—Rash—Thiotepa—sarcoma	0.00012	0.000752	CcSEcCtD
Hydroxyurea—Dermatitis—Thiotepa—sarcoma	0.00012	0.000751	CcSEcCtD
Hydroxyurea—Headache—Thiotepa—sarcoma	0.00012	0.000747	CcSEcCtD
Hydroxyurea—Rash—Dactinomycin—sarcoma	0.000119	0.000746	CcSEcCtD
Hydroxyurea—Decreased appetite—Etoposide—sarcoma	0.000119	0.000744	CcSEcCtD
Hydroxyurea—Pancytopenia—Doxorubicin—sarcoma	0.000119	0.000742	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Etoposide—sarcoma	0.000118	0.000739	CcSEcCtD
Hydroxyurea—Asthenia—Mitoxantrone—sarcoma	0.000118	0.000739	CcSEcCtD
Hydroxyurea—Fatigue—Etoposide—sarcoma	0.000118	0.000738	CcSEcCtD
Hydroxyurea—Neuropathy peripheral—Epirubicin—sarcoma	0.000118	0.000738	CcSEcCtD
Hydroxyurea—Stomatitis—Epirubicin—sarcoma	0.000117	0.000734	CcSEcCtD
Hydroxyurea—Constipation—Etoposide—sarcoma	0.000117	0.000732	CcSEcCtD
Hydroxyurea—Pain—Etoposide—sarcoma	0.000117	0.000732	CcSEcCtD
Hydroxyurea—Dysuria—Doxorubicin—sarcoma	0.000117	0.00073	CcSEcCtD
Hydroxyurea—Neutropenia—Doxorubicin—sarcoma	0.000117	0.00073	CcSEcCtD
Hydroxyurea—Diarrhoea—Vincristine—sarcoma	0.000116	0.000723	CcSEcCtD
Hydroxyurea—Hepatobiliary disease—Epirubicin—sarcoma	0.000114	0.000712	CcSEcCtD
Hydroxyurea—Weight increased—Doxorubicin—sarcoma	0.000114	0.000711	CcSEcCtD
Hydroxyurea—Nausea—Thiotepa—sarcoma	0.000113	0.000708	CcSEcCtD
Hydroxyurea—Feeling abnormal—Etoposide—sarcoma	0.000113	0.000706	CcSEcCtD
Hydroxyurea—Diarrhoea—Mitoxantrone—sarcoma	0.000113	0.000704	CcSEcCtD
Hydroxyurea—Nausea—Dactinomycin—sarcoma	0.000113	0.000703	CcSEcCtD
Hydroxyurea—Dizziness—Vincristine—sarcoma	0.000112	0.000699	CcSEcCtD
Hydroxyurea—Infestation NOS—Doxorubicin—sarcoma	0.000112	0.000696	CcSEcCtD
Hydroxyurea—Infestation—Doxorubicin—sarcoma	0.000112	0.000696	CcSEcCtD
Hydroxyurea—Drowsiness—Doxorubicin—sarcoma	0.000112	0.000696	CcSEcCtD
Hydroxyurea—Neuropathy peripheral—Doxorubicin—sarcoma	0.000109	0.000683	CcSEcCtD
Hydroxyurea—Haemoglobin—Epirubicin—sarcoma	0.000109	0.000679	CcSEcCtD
Hydroxyurea—Stomatitis—Doxorubicin—sarcoma	0.000109	0.000679	CcSEcCtD
Hydroxyurea—Body temperature increased—Etoposide—sarcoma	0.000108	0.000677	CcSEcCtD
Hydroxyurea—Haemorrhage—Epirubicin—sarcoma	0.000108	0.000676	CcSEcCtD
Hydroxyurea—Vomiting—Vincristine—sarcoma	0.000108	0.000672	CcSEcCtD
Hydroxyurea—Rash—Vincristine—sarcoma	0.000107	0.000667	CcSEcCtD
Hydroxyurea—Dermatitis—Vincristine—sarcoma	0.000107	0.000666	CcSEcCtD
Hydroxyurea—Headache—Vincristine—sarcoma	0.000106	0.000662	CcSEcCtD
Hydroxyurea—Hepatobiliary disease—Doxorubicin—sarcoma	0.000105	0.000659	CcSEcCtD
Hydroxyurea—Vomiting—Mitoxantrone—sarcoma	0.000105	0.000655	CcSEcCtD
Hydroxyurea—Rash—Mitoxantrone—sarcoma	0.000104	0.000649	CcSEcCtD
Hydroxyurea—Dermatitis—Mitoxantrone—sarcoma	0.000104	0.000649	CcSEcCtD
Hydroxyurea—Headache—Mitoxantrone—sarcoma	0.000103	0.000645	CcSEcCtD
Hydroxyurea—Hypersensitivity—Etoposide—sarcoma	0.000101	0.000631	CcSEcCtD
Hydroxyurea—Haemoglobin—Doxorubicin—sarcoma	0.000101	0.000628	CcSEcCtD
Hydroxyurea—Nausea—Vincristine—sarcoma	0.000101	0.000628	CcSEcCtD
Hydroxyurea—Haemorrhage—Doxorubicin—sarcoma	0.0001	0.000625	CcSEcCtD
Hydroxyurea—Asthenia—Etoposide—sarcoma	9.84e-05	0.000614	CcSEcCtD
Hydroxyurea—Angiopathy—Epirubicin—sarcoma	9.82e-05	0.000613	CcSEcCtD
Hydroxyurea—Nausea—Mitoxantrone—sarcoma	9.79e-05	0.000612	CcSEcCtD
Hydroxyurea—Chills—Epirubicin—sarcoma	9.71e-05	0.000606	CcSEcCtD
Hydroxyurea—Alopecia—Epirubicin—sarcoma	9.56e-05	0.000597	CcSEcCtD
Hydroxyurea—Erythema—Epirubicin—sarcoma	9.42e-05	0.000588	CcSEcCtD
Hydroxyurea—Diarrhoea—Etoposide—sarcoma	9.38e-05	0.000586	CcSEcCtD
Hydroxyurea—Angiopathy—Doxorubicin—sarcoma	9.08e-05	0.000567	CcSEcCtD
Hydroxyurea—Dizziness—Etoposide—sarcoma	9.07e-05	0.000566	CcSEcCtD
Hydroxyurea—Chills—Doxorubicin—sarcoma	8.98e-05	0.000561	CcSEcCtD
Hydroxyurea—Alopecia—Doxorubicin—sarcoma	8.85e-05	0.000552	CcSEcCtD
Hydroxyurea—Ill-defined disorder—Epirubicin—sarcoma	8.74e-05	0.000546	CcSEcCtD
Hydroxyurea—Vomiting—Etoposide—sarcoma	8.72e-05	0.000544	CcSEcCtD
Hydroxyurea—Erythema—Doxorubicin—sarcoma	8.71e-05	0.000544	CcSEcCtD
Hydroxyurea—Anaemia—Epirubicin—sarcoma	8.7e-05	0.000544	CcSEcCtD
Hydroxyurea—Rash—Etoposide—sarcoma	8.65e-05	0.00054	CcSEcCtD
Hydroxyurea—Dermatitis—Etoposide—sarcoma	8.64e-05	0.000539	CcSEcCtD
Hydroxyurea—Headache—Etoposide—sarcoma	8.59e-05	0.000536	CcSEcCtD
Hydroxyurea—Malaise—Epirubicin—sarcoma	8.49e-05	0.00053	CcSEcCtD
Hydroxyurea—Leukopenia—Epirubicin—sarcoma	8.43e-05	0.000526	CcSEcCtD
Hydroxyurea—Convulsion—Epirubicin—sarcoma	8.16e-05	0.00051	CcSEcCtD
Hydroxyurea—Nausea—Etoposide—sarcoma	8.14e-05	0.000509	CcSEcCtD
Hydroxyurea—Ill-defined disorder—Doxorubicin—sarcoma	8.09e-05	0.000505	CcSEcCtD
Hydroxyurea—Anaemia—Doxorubicin—sarcoma	8.05e-05	0.000503	CcSEcCtD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	7.96e-05	0.000497	CcSEcCtD
Hydroxyurea—Discomfort—Epirubicin—sarcoma	7.92e-05	0.000495	CcSEcCtD
Hydroxyurea—Malaise—Doxorubicin—sarcoma	7.86e-05	0.000491	CcSEcCtD
Hydroxyurea—Leukopenia—Doxorubicin—sarcoma	7.8e-05	0.000487	CcSEcCtD
Hydroxyurea—Oedema—Epirubicin—sarcoma	7.69e-05	0.00048	CcSEcCtD
Hydroxyurea—Infection—Epirubicin—sarcoma	7.64e-05	0.000477	CcSEcCtD
Hydroxyurea—Convulsion—Doxorubicin—sarcoma	7.55e-05	0.000472	CcSEcCtD
Hydroxyurea—Nervous system disorder—Epirubicin—sarcoma	7.54e-05	0.000471	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Epirubicin—sarcoma	7.53e-05	0.00047	CcSEcCtD
Hydroxyurea—Skin disorder—Epirubicin—sarcoma	7.47e-05	0.000466	CcSEcCtD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	7.37e-05	0.00046	CcSEcCtD
Hydroxyurea—Discomfort—Doxorubicin—sarcoma	7.33e-05	0.000458	CcSEcCtD
Hydroxyurea—Anorexia—Epirubicin—sarcoma	7.33e-05	0.000458	CcSEcCtD
Hydroxyurea—Oedema—Doxorubicin—sarcoma	7.11e-05	0.000444	CcSEcCtD
Hydroxyurea—Infection—Doxorubicin—sarcoma	7.07e-05	0.000441	CcSEcCtD
Hydroxyurea—Nervous system disorder—Doxorubicin—sarcoma	6.97e-05	0.000436	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Doxorubicin—sarcoma	6.96e-05	0.000435	CcSEcCtD
Hydroxyurea—Skin disorder—Doxorubicin—sarcoma	6.91e-05	0.000431	CcSEcCtD
Hydroxyurea—Dyspnoea—Epirubicin—sarcoma	6.85e-05	0.000428	CcSEcCtD
Hydroxyurea—Somnolence—Epirubicin—sarcoma	6.83e-05	0.000427	CcSEcCtD
Hydroxyurea—Anorexia—Doxorubicin—sarcoma	6.78e-05	0.000423	CcSEcCtD
Hydroxyurea—Dyspepsia—Epirubicin—sarcoma	6.77e-05	0.000423	CcSEcCtD
Hydroxyurea—Decreased appetite—Epirubicin—sarcoma	6.68e-05	0.000417	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Epirubicin—sarcoma	6.64e-05	0.000414	CcSEcCtD
Hydroxyurea—Fatigue—Epirubicin—sarcoma	6.63e-05	0.000414	CcSEcCtD
Hydroxyurea—Pain—Epirubicin—sarcoma	6.57e-05	0.000411	CcSEcCtD
Hydroxyurea—Constipation—Epirubicin—sarcoma	6.57e-05	0.000411	CcSEcCtD
Hydroxyurea—Dyspnoea—Doxorubicin—sarcoma	6.34e-05	0.000396	CcSEcCtD
Hydroxyurea—Feeling abnormal—Epirubicin—sarcoma	6.33e-05	0.000396	CcSEcCtD
Hydroxyurea—Somnolence—Doxorubicin—sarcoma	6.32e-05	0.000395	CcSEcCtD
Hydroxyurea—Dyspepsia—Doxorubicin—sarcoma	6.26e-05	0.000391	CcSEcCtD
Hydroxyurea—Decreased appetite—Doxorubicin—sarcoma	6.18e-05	0.000386	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Doxorubicin—sarcoma	6.14e-05	0.000383	CcSEcCtD
Hydroxyurea—Fatigue—Doxorubicin—sarcoma	6.13e-05	0.000383	CcSEcCtD
Hydroxyurea—Pain—Doxorubicin—sarcoma	6.08e-05	0.00038	CcSEcCtD
Hydroxyurea—Constipation—Doxorubicin—sarcoma	6.08e-05	0.00038	CcSEcCtD
Hydroxyurea—Body temperature increased—Epirubicin—sarcoma	6.08e-05	0.000379	CcSEcCtD
Hydroxyurea—Feeling abnormal—Doxorubicin—sarcoma	5.86e-05	0.000366	CcSEcCtD
Hydroxyurea—Hypersensitivity—Epirubicin—sarcoma	5.66e-05	0.000354	CcSEcCtD
Hydroxyurea—Body temperature increased—Doxorubicin—sarcoma	5.62e-05	0.000351	CcSEcCtD
Hydroxyurea—Asthenia—Epirubicin—sarcoma	5.51e-05	0.000344	CcSEcCtD
Hydroxyurea—Diarrhoea—Epirubicin—sarcoma	5.26e-05	0.000328	CcSEcCtD
Hydroxyurea—Hypersensitivity—Doxorubicin—sarcoma	5.24e-05	0.000327	CcSEcCtD
Hydroxyurea—Asthenia—Doxorubicin—sarcoma	5.1e-05	0.000319	CcSEcCtD
Hydroxyurea—Dizziness—Epirubicin—sarcoma	5.08e-05	0.000317	CcSEcCtD
Hydroxyurea—Vomiting—Epirubicin—sarcoma	4.89e-05	0.000305	CcSEcCtD
Hydroxyurea—Diarrhoea—Doxorubicin—sarcoma	4.87e-05	0.000304	CcSEcCtD
Hydroxyurea—Rash—Epirubicin—sarcoma	4.85e-05	0.000303	CcSEcCtD
Hydroxyurea—Dermatitis—Epirubicin—sarcoma	4.84e-05	0.000302	CcSEcCtD
Hydroxyurea—Headache—Epirubicin—sarcoma	4.82e-05	0.000301	CcSEcCtD
Hydroxyurea—Dizziness—Doxorubicin—sarcoma	4.7e-05	0.000294	CcSEcCtD
Hydroxyurea—Nausea—Epirubicin—sarcoma	4.57e-05	0.000285	CcSEcCtD
Hydroxyurea—Vomiting—Doxorubicin—sarcoma	4.52e-05	0.000282	CcSEcCtD
Hydroxyurea—Rash—Doxorubicin—sarcoma	4.48e-05	0.00028	CcSEcCtD
Hydroxyurea—Dermatitis—Doxorubicin—sarcoma	4.48e-05	0.00028	CcSEcCtD
Hydroxyurea—Headache—Doxorubicin—sarcoma	4.46e-05	0.000278	CcSEcCtD
Hydroxyurea—Nausea—Doxorubicin—sarcoma	4.22e-05	0.000264	CcSEcCtD
